So far, LinkZill has served hundreds of technology companies, universities, and research institutes worldwide with the core technology of thin-film transistor (TFT) semiconductor biochips. LinkZill's core team members come from highly-reputed universities across the border, including the University of Cambridge, the University of Florida, Leibniz-Gemeinschaft, Shanghai Jiao Tong University, Huazhong University of Science and Technology, the University of Hong Kong, the Hong Kong Polytechnic University, etc., with extensive experience in the biological and semiconductor industries from BGI, BOE, TCL CSOT, Tianma Microelectronics, and other leading companies.
LinkZill connects TFT semiconductors of life sciences to create a TFT semiconductor biochip platform based on three essential technologies for Microarray reaction control, Picoliter droplet manipulation, and In-situ signal sensing. These capabilities would handle the emerging designs brought by artificial intelligence with an efficient solution that excels in high-throughput, cost, integration, and miniaturization of Build/Test for R&D in synthetic biology.
LinkZill combines TFT semiconductor technology with various fields of life sciences with the TFT semiconductor biochip platform that achieved industrial applications in high-throughput DNA synthesis, precise droplet manipulation, in vitro diagnostic IVD, and biological signal sensing. LinkZill's core products are TFT semiconductors for biochips, customization, standardized products, and compatible electronic systems for TFT. Compared to traditional methods, TFT chips prevail in high throughput, balanced capacity, high precision, large area, low cost, and expansibility from processing to functionalities.